Clinical Trials Browser

Phase 3 × INDUSTRY × Hemophilia A × Clear all

NCT06716814 2026-04-20

LIBERTY

Phase 3 Recruiting

Classical hematologyLymphoid

Blood Coagulation Disorders, Hemophilia A, Lymphoma, Follicular, Coagulation Protein Disorders

NCT03020160 2023-01-11

HAVEN 4

Phase 3 Completed

48 enrolled 44 charts 1 FDA

Classical hematology

Hemophilia A

NCT02847637 2022-11-16

HAVEN 3

Phase 3 Completed

152 enrolled 46 charts 1 FDA

Classical hematology

Hemophilia A

NCT02622321 2021-06-24

HAVEN 1

Phase 3 Completed

113 enrolled 45 charts 1 FDA

Classical hematology

Hemophilia A

NCT02795767 2021-06-02

HAVEN 2

Phase 3 Completed

88 enrolled 65 charts 1 FDA

Classical hematology

Hemophilia A

NCT00037544 2008-04-22

Study Evaluating ReFacto AF in Severe Hemophilia A

Phase 3 Completed

Classical hematologyLymphoid

Hemophilia A, Lymphoma, Follicular